Defining the Lowest Threshold for Amyloid-PET to Predict Future Cognitive Decline and Amyloid Accumulation

被引：77

作者：

Farrell, Michelle E. ^{[1
]}

Jiang, Shu ^{[1
,3
,4
]}

Schultz, Aaron P. ^{[1
]}

Properzi, Michael J. ^{[1
]}

Price, Julie C. ^{[2
]}

Becker, J. Alex ^{[2
]}

Jacobs, Heidi I. L. ^{[2
,5
]}

Hanseeuw, Bernard J. ^{[2
,6
]}

Rentz, Dorene M. ^{[1
,7
]}

Villemagne, Victor L. ^{[8
]}

Papp, Kathryn, V ^{[1
,7
]}

Mormino, Elizabeth C. ^{[9
]}

Betensky, Rebecca A. ^{[1
,3
,10
]}

Johnson, Keith A. ^{[1
,2
]}

Sperling, Reisa A. ^{[1
,7
]}

Buckley, Rachel F. ^{[1
,7
,11
]}

机构：

[1] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA

[2] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA

[3] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA

[4] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA

[5] Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Med & Life Sci,Fac Hlth, Maastricht, Netherlands

[6] Catholic Univ Louvain, Clin Univ St Luc, Brussels, Belgium

[7] Brigham & Womens Hosp, Ctr Alzheimer Res & Treatment, 75 Francis St, Boston, MA 02115 USA

[8] Austin Hlth, Dept Mol Imaging & Therapy, Melbourne, Vic, Australia

[9] Stanford Univ, Dept Neurosci, Palo Alto, CA 94304 USA

[10] NYU, Sch Global Publ Hlth, Dept Biostat, New York, NY 10003 USA

[11] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia

来源：

NEUROLOGY | 2021年 / 96卷 / 04期

基金：

加拿大健康研究院;

关键词：

ALZHEIMERS-DISEASE; APOE EPSILON-4; BETA; NEURODEGENERATION; ASSOCIATION; BIOMARKERS; DEPOSITION; PROGRESS; CORE;

D O I：

10.1212/WNL.0000000000011214

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Introduction As clinical trials move toward earlier intervention, we sought to redefine the beta-amyloid (A beta)-PET threshold based on the lowest point in a baseline distribution that robustly predicts future A beta accumulation and cognitive decline in 3 independent samples of clinically normal individuals. Methods Sequential A beta cutoffs were tested to identify the lowest cutoff associated with future change in cognition (Preclinical Alzheimer Cognitive Composite [PACC]) and A beta-PET in clinically normal participants from the Harvard Aging Brain Study (n = 342), Australian Imaging, Biomarker and Lifestyle study of aging (n = 157), and Alzheimer's Disease Neuroimaging Initiative (n = 356). Results Within samples, cutoffs derived from future A beta-PET accumulation and PACC decline converged on the same inflection point, beyond which trajectories diverged from normal. Across samples, optimal cutoffs fell within a short range (Centiloid 15-18.5). Discussion These optimized thresholds can help to inform future research and clinical trials targeting early A beta. Threshold convergence raises the possibility of contemporaneous early changes in A beta and cognition.

引用

页码：E619 / E631

页数：13

共 52 条

[41] 18F-Florbetaben PET beta-amyloid binding expressed in Centiloids [J].

Rowe, Christopher C. ;

Dore, Vincent ;

Jones, Gareth ;

Baxendale, David ;

Mulligan, Rachel S. ;

Bullich, Santiago ;

Stephens, Andrew W. ;

De Santi, Susan ;

Masters, Colin L. ;

Dinkelborg, Ludger ;

Villemagne, Victor L. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (12) :2053-2059

[42] Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging [J].

Rowe, Christopher C. ;

Ellis, Kathryn A. ;

Rimajova, Miroslava ;

Bourgeat, Pierrick ;

Pike, Kerryn E. ;

Jones, Gareth ;

Fripp, Jurgen ;

Tochon-Danguy, Henri ;

Morandeau, Laurence ;

O'Keefe, Graeme ;

Price, Roger ;

Raniga, Parnesh ;

Robins, Peter ;

Acosta, Oscar ;

Lenzo, Nat ;

Szoeke, Cassandra ;

Salvado, Olivier ;

Head, Richard ;

Martins, Ralph ;

Masters, Colin L. ;

Ames, David ;

Villemagne, Victor L. .

NEUROBIOLOGY OF AGING, 2010, 31 (08) :1275-1283

[43] Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers [J].

Salvado, Gemma ;

Luis Molinuevo, Jose ;

Brugulat-Serrat, Anna ;

Falcon, Carles ;

Grau-Rivera, Oriol ;

Suarez-Calvet, Marc ;

Pavia, Javier ;

Ninerola-Baizan, Aida ;

Perissinotti, Andres ;

Lomena, Francisco ;

Minguillon, Carolina ;

Fauria, Karine ;

Zetterberg, Henrik ;

Blennow, Kaj ;

Domingo Gispert, Juan ;

Cami, Jordi ;

Cacciaglia, Raffaele ;

Crous-Bou, Marta ;

Deulofeu, Carme ;

Dominguez, Ruth ;

Gotsens, Xavi ;

Gramunt, Nina ;

Hernandez, Laura ;

Huesa, Gema ;

Huguet, Jordi ;

Leon, Maria ;

Marne, Paula ;

Menchon, Tania ;

Mila, Marta ;

Operto, Gregory ;

Pascual, Maria ;

Polo, Albina ;

Pradas, Sandra ;

Sala-Vila, Aleix ;

Sanchez-Benavides, Gonzalo ;

Segundo, Sabrina ;

Soteras, Anna ;

Tenas, Laia ;

Vilanova, Marc ;

Vilor-Tejedor, Natalia .

ALZHEIMERS RESEARCH & THERAPY, 2019, 11 (1)

[44] ESTIMATING DIMENSION OF A MODEL [J].

SCHWARZ, G .

ANNALS OF STATISTICS, 1978, 6 (02) :461-464

[45] The Evolution of Preclinical Alzheimer's Disease: Implications for Prevention Trials [J].

Sperling, Reisa ;

Mormino, Elizabeth ;

Johnson, Keith .

NEURON, 2014, 84 (03) :608-622

[46] The A4 Study: Stopping AD Before Symptoms Begin? [J].

Sperling, Reisa A. ;

Rentz, Dorene M. ;

Johnson, Keith A. ;

Karlawish, Jason ;

Donohue, Michael ;

Salmon, David P. ;

Aisen, Paul .

SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (228)

[47] Testing the Right Target and Right Drug at the Right Stage [J].

Sperling, Reisa A. ;

Jack, Clifford R., Jr. ;

Aisen, Paul S. .

SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (111)

[48] Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease [J].

Sperling, Reisa A. ;

Aisen, Paul S. ;

Beckett, Laurel A. ;

Bennett, David A. ;

Craft, Suzanne ;

Fagan, Anne M. ;

Iwatsubo, Takeshi ;

Jack, Clifford R., Jr. ;

Kaye, Jeffrey ;

Montine, Thomas J. ;

Park, Denise C. ;

Reiman, Eric M. ;

Rowe, Christopher C. ;

Siemers, Eric ;

Stern, Yaakov ;

Yaffe, Kristine ;

Carrillo, Maria C. ;

Thies, Bill ;

Morrison-Bogorad, Marcelle ;

Wagster, Molly V. ;

Phelps, Creighton H. .

ALZHEIMERS & DEMENTIA, 2011, 7 (03) :280-292

[49] Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies [J].

Su, Yi ;

Flores, Shaney ;

Hornbeck, Russ C. ;

Speidel, Benjamin ;

Vlassenko, Andrei G. ;

Gordon, Brian A. ;

Koeppe, Robert A. ;

Klunk, William E. ;

Xiong, Chengjie ;

Morris, John C. ;

Benzinge, Tammie L. S. .

NEUROIMAGE-CLINICAL, 2018, 19 :406-416

[50] Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study [J].

Villemagne, Victor L. ;

Burnham, Samantha ;

Bourgeat, Pierrick ;

Brown, Belinda ;

Ellis, Kathryn A. ;

Salvado, Olivier ;

Szoeke, Cassandra ;

Macaulay, S. Lance ;

Martins, Ralph ;

Maruff, Paul ;

Ames, David ;

Rowe, Christopher C. ;

Masters, Colin L. .

LANCET NEUROLOGY, 2013, 12 (04) :357-367

← 1 2 3 4 5 6 →